CA2325016A1 - Compositions contenant des sequences ns5b du virus de l'hepatite c et leurs procedes d'utilisation - Google Patents

Compositions contenant des sequences ns5b du virus de l'hepatite c et leurs procedes d'utilisation Download PDF

Info

Publication number
CA2325016A1
CA2325016A1 CA002325016A CA2325016A CA2325016A1 CA 2325016 A1 CA2325016 A1 CA 2325016A1 CA 002325016 A CA002325016 A CA 002325016A CA 2325016 A CA2325016 A CA 2325016A CA 2325016 A1 CA2325016 A1 CA 2325016A1
Authority
CA
Canada
Prior art keywords
seq
protein
hepatitis
sequence
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002325016A
Other languages
English (en)
Inventor
Marc S. Collett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viropharma Biologics LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2325016A1 publication Critical patent/CA2325016A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

L'invention concerne des acides nucléiques et des protéines de NS5B de HCV. Elle concerne également des procédés et des trousses mettant en application ces compositions.
CA002325016A 1998-04-02 1999-04-02 Compositions contenant des sequences ns5b du virus de l'hepatite c et leurs procedes d'utilisation Abandoned CA2325016A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8050998P 1998-04-02 1998-04-02
US60/080,509 1998-04-02
US9035698P 1998-06-23 1998-06-23
US60/090,356 1998-06-23
PCT/US1999/007404 WO1999051781A1 (fr) 1998-04-02 1999-04-02 Compositions contenant des sequences ns5b du virus de l'hepatite c et leurs procedes d'utilisation

Publications (1)

Publication Number Publication Date
CA2325016A1 true CA2325016A1 (fr) 1999-10-14

Family

ID=26763614

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002325016A Abandoned CA2325016A1 (fr) 1998-04-02 1999-04-02 Compositions contenant des sequences ns5b du virus de l'hepatite c et leurs procedes d'utilisation

Country Status (6)

Country Link
EP (1) EP1068362A4 (fr)
JP (1) JP2002510509A (fr)
AU (1) AU768177B2 (fr)
CA (1) CA2325016A1 (fr)
IL (1) IL138804A0 (fr)
WO (1) WO1999051781A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461845B1 (en) * 1995-09-27 2002-10-08 Emory University Recombinant hepatitis C virus RNA replicase
AU2044701A (en) * 1999-11-23 2001-06-04 University Of Florida Polymerase compositions and methods of use thereof
US7018796B2 (en) 2000-04-07 2006-03-28 Shionogi & Co., Ltd. Preincubation assay methods
EP1283267A4 (fr) * 2000-05-15 2004-05-12 Tokyo Metropolitan Org Med Res Vecteur permettant d'analyser le mecanisme de replication d'un virus a arn et utilisation de ce vecteur
US20040110126A1 (en) * 2001-03-08 2004-06-10 George Kukolj Hcv polymerase inhibitor assay
EP1256628A3 (fr) * 2001-05-10 2003-03-19 Agouron Pharmaceuticals, Inc. ARN polymerase NS5B du virus de la hepatite C et mutants derivés de la polymerase
WO2005070957A1 (fr) * 2004-01-09 2005-08-04 Merck & Co., Inc. Arn polymerase dependant de l'arn du vhc
EP2236624B1 (fr) * 2007-08-09 2012-11-07 Federalnoe Gosudarstvennoe Byudzhetnoe Uchrezhdenie Nauki Institut Molekulyarnoi Biologi Im. V.A. Engelgardta Rossiiskoi Akademii Nauk Procédé d'identification du génotype et du sous-type du virus de l'hépatite c sur une biopuce

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
AU7675491A (en) * 1990-04-04 1991-10-30 Chiron Corporation Hepatitis c virus protease
IT1278077B1 (it) * 1995-05-25 1997-11-17 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
AU719122B2 (en) * 1995-09-27 2000-05-04 Emory University Recombinant hepatitis C virus RNA replicase

Also Published As

Publication number Publication date
WO1999051781A1 (fr) 1999-10-14
AU768177B2 (en) 2003-12-04
JP2002510509A (ja) 2002-04-09
EP1068362A1 (fr) 2001-01-17
WO1999051781A9 (fr) 2000-05-04
IL138804A0 (en) 2001-10-31
EP1068362A4 (fr) 2005-07-20
AU3861099A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
EP0998585B1 (fr) Methodes de criblage utilisant une proteine atpase provenant d'un virus de la famille des flaviviridae
ES2298585T3 (es) Ns3 proteasa de hcv resistente a inhibidores.
US7785604B2 (en) Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
CN1125877C (zh) 庚型肝炎病毒及其分子克隆
US20040110126A1 (en) Hcv polymerase inhibitor assay
AU768177B2 (en) Hepatitis C virus NS5B compositions and methods of use thereof
US20070160629A1 (en) Purified active HCV NS2/3 protease
US20020081574A1 (en) Methods for identifying inhibitors of helicase C virus
Marín et al. ATP binding and ATPase activities associated with recombinant rabbit hemorrhagic disease virus 2C-like polypeptide
JPH07503230A (ja) 乳頭腫ウイルス疾患の治療用薬剤
US7329732B2 (en) HCV RNA-dependent RNA polymerase
US20120003256A1 (en) Tuberculosis antigens, immunogenic compositions, diagnostics and methods related to the same
US20150072418A1 (en) Hcv genotype 4d replicons
KR20170056902A (ko) C형 간염 바이러스 감염 또는 감염과 관련된 질병의 예방 또는 치료용 약학 조성물
CA2120499A1 (fr) Methodes et compositions pour l'identification des inhibiteurs de la replication du papillomavirus
WO2001038538A1 (fr) Compositions de polymerase et procedes d'utilisation correspondants
JP2003526361A (ja) Hcvns2/3フラグメント及びその使用
US20010034019A1 (en) Chimeric HCV/GBV-B viruses
AU2002244566B2 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV
JP5607528B2 (ja) 肝炎患者の血液に見出される核酸およびそれがコードするポリペプチドならびにそれらの利用
JP4710001B2 (ja) マダニのロイシンアミノペプチダーゼ
KR100946170B1 (ko) 항 ns5b 항체를 포함하는 c형 간염 바이러스 매개간질환 예방 및 치료제
Pentón et al. Antigenicity of a recombinant NS3 protein representative of ATPase/helicase domain from hepatitis C virus
WO1999043792A1 (fr) Proteine de recombinaison presentant une activite polymerase dependant de l'arn du virus de l'hepatite c humain et procede de production de cette derniere
Tsai et al. Hepatitis C Virus Core Protein Interacts

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued